If Maynes womans health products stand up to scrutiny and we have for the most part enough positive feedback from the majority of users . Being one of the few companies specializing in womans health if our products are for the most part are well received a major hurdle in itself but if they are Mayne Pharma's name would be well known in the US for all the right reasons but products are needing to be proven to be as good as we're led to believe they are the real test being enough positive feedback / reviews . The US market we're selling into is big real risk reward stuff believe risk probably worth taking considering reward . Management residing in the States for the most part seem experienced and well qualified in pharma + familiar with the way things are done / work over there .
MYX Price at posting:
$5.27 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)